You are here: Introduction > Contra-indications, warnings, etc
 
        PreviousNext
 
Pardale-V Oral Tablets:  Contra-indications, warnings, etc
 
 
Pardale-V Oral Tablets
Contra-indications, warnings, etc
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, or where there is evidence of blood dyscrasia or hypersensitivity to the product.
Do not use this preparation for cats.
Use in animals less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Some NSAIDS may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Overdosage: Immediately seek the advice of a veterinary surgeon showing them the product literature.
Carry out lavage and treat with an intravenous injection of Acetylcysteine (200 mg/ml) at a rate of 140 mg/kg every 6 hours for 7 treatments. Ascorbic Acid (30 mg/kg) should also be given orally with each dose of Acetylcysteine. If necessary, instigate fluid therapy using Ringers or Bicarbonate Solution. Treat for Codeine overdosing with intravenous injections of Naloxone (1.0 mg/kg) repeated as necessary. Provide Oxygen support.
Side effects: Occasional constipation due to Codeine content.
Operator warnings: Wash hands after use.
General precautions: For animal treatment only.
           
 
        PreviousNext
  Date updated: 28 September 2007